Bayer Aktiengesellschaft (ETR:BAYN) Stock Price Down 1.3% – Here’s What Happened

Bayer Aktiengesellschaft (ETR:BAYNGet Free Report)’s share price dropped 1.3% during mid-day trading on Tuesday . The stock traded as low as €19.22 ($20.23) and last traded at €19.50 ($20.53). Approximately 4,583,339 shares traded hands during mid-day trading, The stock had previously closed at €19.76 ($20.80).

Bayer Aktiengesellschaft Trading Down 0.9 %

The business’s 50-day moving average is €22.76 and its two-hundred day moving average is €25.79. The company has a current ratio of 1.27, a quick ratio of 0.72 and a debt-to-equity ratio of 129.94. The stock has a market capitalization of $18.99 billion, a PE ratio of -15.12, a PEG ratio of 36.39 and a beta of 0.97.

About Bayer Aktiengesellschaft

(Get Free Report)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Further Reading

Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.